Literature DB >> 2998598

Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells.

N C Luetteke, G K Michalopoulos.   

Abstract

Serum-free medium conditioned by confluent cultures of JM1 of JM2 rat hepatocellular carcinoma cells stimulated DNA synthesis in primary cultures of adult rat hepatocytes in a dose-dependent, saturable manner and in the absence of epidermal growth factor. The hepatotrophic activity was nondialyzable in Mr 50,000 cutoff membranes, heat (60 degrees C) and acid stable, and sensitive to trypsin and dithiothreitol treatment. Gel filtration of concentrated JM1 or JM2 conditioned medium on Sephadex G-100 separated the activity into two regions, the major broad peak migrating with apparent Mr 25,000. Chromatography fractions active in the hepatocyte proliferation bioassay also inhibited specific binding of iodinated epidermal growth factor to cultures of A431 carcinoma cells and rat hepatocytes. These results suggest that neoplastic liver cells synthesize and secrete polypeptide growth factors which can bind to epidermal growth factor receptors and stimulate proliferation of normal adult rat hepatocytes in primary culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998598

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.

Authors:  Gang Wei; Meifang Wang; Terry Hyslop; Ziqiu Wang; Brian I Carr
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

2.  Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice.

Authors:  Xiao-Ping Chen; Xin-Ping Ren; Jian-Yun Lan; You-Guo Chen; Zong-Ji Shen
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

3.  Hepatopoietins A and B and hepatocyte growth.

Authors:  G K Michalopoulos; R Zarnegar; K Houck; P Pediaditakis
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

4.  Preneoplastic rat liver cells in vitro: slow progression without promoters, hormones, or growth factors.

Authors:  R Kerler; H M Rabes
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway.

Authors:  Hsien-Te Chen; Hsi-Kai Tsou; Chia-Hao Chang; Chih-Hsin Tang
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

Review 6.  Growth-related alterations during liver carcinogenesis: effect of promoters.

Authors:  P O Seglen; P Gerlyng
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

7.  Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF.

Authors:  Jong Kyu Woo; Ju-Hee Kang; BoRa Kim; Byung Hee Park; Kum-Joo Shin; Seong-Won Song; Jung Ju Kim; Hwan-Mook Kim; Sang-Jin Lee; Seung Hyun Oh
Journal:  Oncotarget       Date:  2015-09-15

8.  HGF and c-Met interaction promotes migration in human chondrosarcoma cells.

Authors:  Hsi-Kai Tsou; Hsien-Te Chen; Ya-Huey Hung; Chia-Hao Chang; Te-Mao Li; Yi-Chin Fong; Chih-Hsin Tang
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

9.  Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway.

Authors:  Yu-Min Lin; Yuan-Li Huang; Yi-Chin Fong; Chun-Hao Tsai; Ming-Chih Chou; Chih-Hsin Tang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.